Dollery Clare M, Owen Caroline A, Sukhova Galina K, Krettek Alexandra, Shapiro Steven D, Libby Peter
Leducq Center for Cardiovascular Research, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, EBRC 307, Boston, Mass 02115, USA.
Circulation. 2003 Jun 10;107(22):2829-36. doi: 10.1161/01.CIR.0000072792.65250.4A. Epub 2003 May 27.
Catabolism of the extracellular matrix (ECM) contributes to vascular remodeling in health and disease. Although metalloenzymes and cysteinyl proteinases have garnered much attention in this regard, the role of serine-dependent proteinases in vascular ECM degradation during atherogenesis remains unknown. We recently discovered the presence of the metalloproteinase MMP-8, traditionally associated only with neutrophils, in atheroma-related cells. Human neutrophil elastase (NE) plays a critical role in lung disease, but the paucity of neutrophils in the atheromatous plaque has led to neglect of its potential role in vascular biology. NE can digest elastin, fibrillar and nonfibrillar collagens, and other ECM components in addition to its ability to modify lipoproteins and modulate cytokine and MMP activity.
Fibrous and atheromatous plaques but not normal arteries contained NE. In particular, NE abounded in the macrophage-rich shoulders of atheromatous plaques with histological features of vulnerability. Neutrophil elastase and macrophages colocalized in such vulnerable plaques (n=7). In situ hybridization revealed NE mRNA in macrophage-rich areas, indicating local production of this enzyme. Freshly isolated blood monocytes, monocyte-derived macrophages, and vascular endothelial cells in culture produced active NE and contained NE mRNA. Monocytes produced NE constitutively, with little regulation by cytokines IL-1beta, TNF-alpha, or IFN-gamma but released it when stimulated by CD40 ligand, a cytokine found in atheroma.
These findings point to a novel role for the serine protease, neutrophil elastase, in matrix breakdown by macrophages, a critical process in adaptive remodeling of vessels and in the pathogenesis of arterial diseases.
细胞外基质(ECM)的分解代谢在健康和疾病状态下均参与血管重塑。尽管金属酶和半胱氨酸蛋白酶在这方面已备受关注,但丝氨酸依赖性蛋白酶在动脉粥样硬化形成过程中对血管ECM降解的作用仍不清楚。我们最近在动脉粥样硬化相关细胞中发现了金属蛋白酶MMP - 8的存在,传统上它仅与中性粒细胞相关。人类中性粒细胞弹性蛋白酶(NE)在肺部疾病中起关键作用,但动脉粥样硬化斑块中中性粒细胞数量稀少,导致其在血管生物学中的潜在作用被忽视。除了能够修饰脂蛋白以及调节细胞因子和MMP活性外,NE还可以消化弹性蛋白、纤维状和非纤维状胶原蛋白以及其他ECM成分。
纤维斑块和动脉粥样硬化斑块中含有NE,但正常动脉中没有。特别是,NE在具有易损组织学特征的动脉粥样硬化斑块富含巨噬细胞的肩部大量存在。中性粒细胞弹性蛋白酶和巨噬细胞在这些易损斑块中(n = 7)共定位。原位杂交显示在富含巨噬细胞的区域有NE mRNA,表明该酶在局部产生。新鲜分离的血液单核细胞、单核细胞衍生的巨噬细胞以及培养的血管内皮细胞产生活性NE并含有NE mRNA。单核细胞持续产生NE,几乎不受细胞因子IL - 1β、TNF - α或IFN - γ的调节,但在受到动脉粥样硬化中发现的细胞因子CD40配体刺激时会释放NE。
这些发现表明丝氨酸蛋白酶中性粒细胞弹性蛋白酶在巨噬细胞介导的基质降解中具有新作用,这是血管适应性重塑和动脉疾病发病机制中的关键过程。